Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omegaven in Severe Sepsis
NCT00634075Phase 4Completed
- Sponsor
- Landseed International Hospital
- Start
- Mar 2008
- Primary completion
- Aug 2009
- Modality
- Lipid-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 4 trial of eicosapentaenoic acid + docosahexaenoic acid in sepsis, sponsored by Landseed International Hospital. Started Mar 2008; status: completed.
02
Drugs
eicosapentaenoic acid + docosahexaenoic acid
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT00634075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00634075.